SNPS

SNPS

Synopsys

Recurring SaaS

★ Quality 36/100
Overvalued

Price today

$393.84

This company value is already calculated

We know what it is worth from its audited numbers, and whether it trades above or below that today. Create your free account to see it.

See what it is worth

charlieapp.co

🏆

A monopoly position

This company has a competitive advantage so strong that its rivals find it practically impossible to replicate.

What this business is made of

36qualityReturnsMoatBalance sheetPricing powerReinvestment

The business

Synopsys is the printing press without which no advanced chip gets born.

Synopsys sells the EDA tools used to design chips: software that simulates, verifies, and signs off silicon before it gets manufactured. It charges for recurring multi-year licenses plus IP embedded in the designs, which gives it $7.1B in revenue with a 77% gross margin. Without its tools, nobody brings an advanced chip to production.

Together with Cadence it forms a real duopoly: any chip from Nvidia, Apple, or TSMC runs through its software. The switching cost is brutal because a design team takes years to master the flow and one migration error costs a tape-out worth millions. The Ansys acquisition adds physical simulation to the same flow, deepening the moat.

Revenue history

$4.2B
2021
$5.1B
2022
$5.8B
2023
$6.1B
2024
$7.1B
2025
CAGR 5 años: +14%

From $4.2B to $7.1B in 4 years. The business grows steadily.

Where each $100 of sales goes

Revenue $7.1B · FY2025

Cost of sales$1.6B · 23%
Operations and taxes$4.1B · 58%
Net profit$1.3B · 19%

Of every $100 in sales, $81 goes to costs and operations; $19 is left as net profit (19% margin).

Catalysts and risks

Ansys integration (closed July 2025, ~$35B) expanding the addressable market toward multiphysics simulation.

AI chip design boom: every hyperscaler designing its own silicon needs more EDA licenses.

Multi-year backlog model that provides visibility: the conversion of RPO to revenue sustains the 14% CAGR.

⚠️

$13.5B of debt against $3.0B of cash after Ansys: the balance sheet lost its cushion.

⚠️

Exposure to China under U.S. export controls that could tighten further.

⚠️

Valuation: at 24.2x on normalized FCFps of $8.14, the intrinsic value of $133.56 leaves little margin if the CAGR disappoints.

Charlie's note

It's a toll on the entire semiconductor industry, and tolls age well. The Ansys debt makes me look twice, but I'd pay for a business where the customer would rather lose an arm than switch providers.

Analysis · June 2026

Want to follow Synopsys?

We do not calculate a value here: Synopsys does not generate cash flows you can project, and putting a number on it would be making it up. What you can do is follow it and tell us the price you care about — we will email you when it gets there.

🔔 Email me

Free · no card

Charlie informs, it doesn't advise. No information should be taken as a recommendation to buy or sell.